Antibiotic resistance is increasing worldwide, and it has been regarded as the main factor reducing the efficacy of Helicobacter pylori therapy. The aim of this study was to determine the phenotype and genotype of antibiotic-resistant strains of H. pylori in the Malaysian population and to evaluate the impact of antibiotic resistance to eradication outcome. One hundred and sixty-one H. pylori isolates were analysed in this study. Metronidazole, clarithromycin, fluoroquinolone, amoxicillin and tetracycline susceptibilities were determined by Etest. PCR followed by DNA sequencing was carried out to determine mutations. The medical records of the patients infected with resistant strains were reviewed to determine the eradication outcome. Metronidazole resistance was encountered in 36.6 % of H. pylori isolates, whereas clarithromycin and fluoroquinolone resistance was observed in 1.2 and 1.9 % of isolates, respectively. All strains tested were susceptible to amoxicillin and tetracycline. Frameshift and nonsense mutations in rdxA and frxA genes resulting in stop codons contributed to metronidazole resistance, which leads to reduced eradication efficacy. A2142G and A2143G mutations of 23S rRNA were identified as causing failure of the eradication therapy. Mutation at either codon 87 or 91 of the gyrA gene was identified in fluoroquinolone-resistant strains. However, the effect of resistance could not be assessed. This study showed that frameshift and nonsense mutations in rdxA or frxA genes and point mutations in the 23S rRNA affected the efficacy of H. pylori eradication therapy.
AhmadN., ZakariaW. R., AbdullahS. A., MohamedR.2009; Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.. World J Gastroenterol 15:3161–3165 [View Article][PubMed]
AhmadN., ZakariaW. R., MohamedR.2011; Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia. Helicobacter 16:47–51 [View Article][PubMed]
BagoJ., MajstorovićK., Belosić-HalleZ., KućisecN., BakulaV., TomićM., BagoP., TroskotR.2010; Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days moxifloxacin based therapy for the eradication: a randomized controlled trial. Ann Clin Microbiol Antimicrob 9:13 [View Article][PubMed]
CattoirV., NectouxJ., LascolsC., DeforgesL., DelchierJ. C., MegraudF., SoussyC. J., CambauE.2007; Update on fluoroquinolone resistance in Helicobacterpylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents 29:389–396 [View Article][PubMed]
ChisholmS. A., OwenR. J.2003; Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance. J Antimicrob Chemother 51:995–999 [View Article][PubMed]
ChisholmS. A., OwenR. J.2004; Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori.. J Med Microbiol 53:135–140 [View Article][PubMed]
ChisholmS. A., OwenR. J.2009; Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK. J Med Microbiol 58:1322–1328 [View Article][PubMed]
De FrancescoV., MargiottaM., ZulloA., HassanC., GiorgioF., BurattiniO., StoppinoG., CeaU., PaceA.& other authors (2007; Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimicrob Chemother 59:783–785 [View Article][PubMed]
HwangT. J., KimN., KimH. B., LeeB. H., NamR. H., ParkJ. H., LeeM. K., ParkY. S., LeeD. H.& other authors (2010; Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol 44:536–543[PubMed]
KimJ. M., KimJ. S., JungH. C., KimN., KimY. J., SongI. S.2004; Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob Agents Chemother 48:4843–4847 [View Article][PubMed]
KimJ. M., KimJ. S., KimN., JungH. C., SongI. S.2005; Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother 56:965–967 [View Article][PubMed]
KwonD. H., El-ZaatariF. A., KatoM., OsatoM. S., ReddyR., YamaokaY., GrahamD. Y.2000; Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacterpylori. Antimicrob Agents Chemother 44:2133–2142 [View Article][PubMed]
MalfertheinerP., MegraudF., O’MorainC., BazzoliF., El-OmarE., GrahamD., HuntR., RokkasT., VakilN., KuipersE. J.2007; Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56:772–781 [View Article][PubMed]
MaraisA., BilardiC., CantetF., MendzG. L., MégraudF.2003; Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori.. Res Microbiol 154:137–144 [View Article][PubMed]
MatteoM. J., PérezC. V., DomingoM. R., OlmosM., SanchezC., CatalanoM.2006; DNA sequence analysis of rdxA and frxA from paired metronidazole-sensitive and -resistant Helicobacter pylori isolates obtained from patients with heteroresistance. Int J Antimicrob Agents 27:152–158 [View Article][PubMed]
RajperS., KhanE., AhmadZ., AlamS. M. Z., AkbarA., HasanR.2012; Macrolide and fluoroquinolone resistance in Helicobacter pylori isolates: an experience at a tertiary care centre in Pakistan. J Pak Med Assoc 62:1140–1144[PubMed]
SeckA., MbengueM., Gassama-SowA., DioufL., KaM. M., BoyeC. S. B.2009; Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal. J Infect Dev Ctries 3:137–140 [View Article][PubMed]
SolcàN. M., BernasconiM. V., PiffarettiJ. C.2000; Mechanism of metronidazole resistance in Helicobacter pylori: comparison of the rdxA gene sequences in 30 strains. Antimicrob Agents Chemother 44:2207–2210 [View Article][PubMed]
SunQ. J., LiangX., ZhengQ., GuW. Q., LiuW. Z., XiaoS. D., LuH.2010; Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World J Gastroenterol 16:5118–5121 [View Article][PubMed]
TankovicJ., LascolsC., SculoQ., PetitJ. C., SoussyC. J.2003; Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.. Antimicrob Agents Chemother 47:3942–3944 [View Article][PubMed]